Targeting Immunophenotypic Markers on Leukemic Stem Cells: How Lessons from Current Approaches and Advances in the Leukemia Stem Cell (LSC) Model Can Inform Better Strategies for Treating Acute Myeloid Leukemia (AML)-Reference-Cited by-同舟云学术

Targeting Immunophenotypic Markers on Leukemic Stem Cells: How Lessons from Current Approaches and Advances in the Leukemia Stem Cell (LSC) Model Can Inform Better Strategies for Treating Acute Myeloid Leukemia (AML)

Published:2019-08-26 Issue:1 Volume:10 Page:a036251
ISSN:2157-1422
Container-title:Cold Spring Harbor Perspectives in Medicine
language:en
Short-container-title:Cold Spring Harb Perspect Med

Author:

Mitchell Kelly,Steidl Ulrich

Publisher

Cold Spring Harbor Laboratory

Subject

General Biochemistry, Genetics and Molecular Biology

Reference233 articles.

1. Prediction of acute myeloid leukaemia risk in healthy individuals

2. Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia

3. CD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabine

4. Treatment with FLT3 inhibitor in patients withFLT3-mutated acute myeloid leukemia is associated with development of secondaryFLT3-tyrosine kinase domain mutations

5. Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19)

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polydopamine-Coated Zn-MOF-74 Nanocarriers: Versatile Drug Delivery Systems with Enhanced Biocompatibility and Cancer Therapeutic Efficacy;Journal of Inorganic and Organometallic Polymers and Materials;2024-07-13

2. Novel Vpx virus-like particles to improve cytarabine treatment response against acute myeloid leukemia;Clinical and Experimental Medicine;2024-07-13

3. Emerging and Future Targeted Therapies for Pediatric Acute Myeloid Leukemia: Targeting the Leukemia Stem Cells;Biomedicines;2023-12-07

4. Tetraspanin CD81 promotes leukemia stem cell function and represents a new therapeutic vulnerability in acute myeloid leukemia;2023-09-26

5. Therapeutic targeting of leukemia stem cells in acute myeloid leukemia;Frontiers in Oncology;2023-08-03